<div id="readability-page-1"><p>Molina Healthcare (NYSE:MOH - Get Free Report) issued an update on its FY 2026 earnings guidance on Thursday morning. The company provided EPS guidance of 5.000- for the period, compared to the consensus EPS estimate of 5.180. The company issued revenue guidance of -.</p><div><p><span></span><span>Get <strong>Molina Healthcare</strong> alerts:</span></p></div><h2>Molina Healthcare Stock Performance</h2><ul><li>3 Sectors to Buy While They're Down and 1 to Walk Away From</li></ul><p>MOH stock opened at $197.96 on Thursday. The firm has a 50 day moving average of $172.30 and a two-hundred day moving average of $163.88. Molina Healthcare has a 12 month low of $121.06 and a 12 month high of $311.52. The company has a market capitalization of $10.31 billion, a price-to-earnings ratio of 58.57 and a beta of 0.80. The company has a quick ratio of 1.63, a current ratio of 1.63 and a debt-to-equity ratio of 0.97. </p><p>Molina Healthcare (NYSE:MOH - Get Free Report) last released its quarterly earnings results on Wednesday, April 22nd. The company reported $2.35 earnings per share for the quarter, beating analysts' consensus estimates of $1.57 by $0.78. The business had revenue of $10.80 billion for the quarter, compared to the consensus estimate of $10.91 billion. Molina Healthcare had a net margin of 0.42% and a return on equity of 8.76%. Molina Healthcare's revenue for the quarter was down 3.1% on a year-over-year basis. During the same quarter last year, the firm earned $6.08 EPS. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS.  As a group, equities analysts anticipate that  Molina Healthcare will post 5.23 EPS for the current fiscal year. </p><h2>Analyst Ratings Changes</h2><ul><li>Why Centene Stock Dropped 40% — And Whether It's a Buy Now</li></ul><p>A number of brokerages have weighed in on MOH. Wells Fargo &amp; Company boosted their price target on Molina Healthcare from $141.00 to $159.00 and gave the stock an &#34;equal weight&#34; rating in a research report on Monday, April 27th. Mizuho  set a $215.00 price objective on Molina Healthcare in a research note on Monday. Bank of America upgraded Molina Healthcare from an &#34;underperform&#34; rating to a &#34;buy&#34; rating and set a $250.00 target price for the company in a report on Wednesday, April 29th. Cantor Fitzgerald lifted their price target on shares of Molina Healthcare from $144.00 to $209.00 and gave the company a &#34;neutral&#34; rating in a research report on Monday, May 11th. Finally, Barclays raised their target price on shares of Molina Healthcare from $161.00 to $199.00 and gave the company an &#34;underweight&#34; rating in a research note on Tuesday, May 26th. Three research analysts have rated the stock with a Buy rating, eleven have issued  a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat, the stock currently has an average rating of &#34;Hold&#34; and an average target price of $182.73.</p><p><b>Check Out Our Latest Analysis on Molina Healthcare</b></p><h2>Insiders Place Their Bets</h2><ul><li>3 Health Insurance Stocks Holding Green in Market Turmoil</li></ul><p>In other Molina Healthcare news, insider Jeff D. Barlow sold 17,811 shares of the stock in a transaction on Monday, May 11th. The shares were sold at an average price of $186.12, for a total value of $3,314,983.32. Following the completion of the sale, the insider directly owned 67,175 shares of the company's stock, valued at $12,502,611. This represents a 20.96% decrease in their position. The sale was disclosed in a document filed with the Securities &amp; Exchange Commission, which is available at this link. Also, CAO Maurice Hebert sold 600 shares of the business's stock in a transaction dated Thursday, May 14th. The stock was sold at an average price of $191.55, for a total transaction of $114,930.00. Following the transaction, the chief accounting officer owned 12,815 shares in the company, valued at approximately $2,454,713.25. The trade was a 4.47% decrease in their position. The SEC filing for this sale provides additional information. 1.44% of the stock is owned by corporate insiders. </p><h2>Hedge Funds Weigh In On Molina Healthcare</h2><p>Hedge funds and other institutional investors have recently made changes to their positions in the business. AQR Capital Management LLC raised its stake in shares of  Molina Healthcare by 217.0% in the third quarter. AQR Capital Management LLC now owns 2,934,130 shares of the company's stock valued at $561,475,000 after acquiring an additional 2,008,458 shares during the last quarter.  T. Rowe Price Investment Management Inc. grew its holdings in  Molina Healthcare by 10.2% during the 4th quarter. T. Rowe Price Investment Management Inc. now owns 2,171,433 shares of the company's stock worth $376,831,000 after acquiring an additional 201,772 shares during the period.  Invesco Ltd. raised its position in shares of  Molina Healthcare by 24.2% during the 4th quarter. Invesco Ltd. now owns 1,690,981 shares of the company's stock valued at $293,453,000 after acquiring an additional 329,679 shares during the last quarter.  Victory Capital Management Inc. lifted its stake in shares of  Molina Healthcare by 46.4% in the 4th quarter. Victory Capital Management Inc. now owns 1,410,604 shares of the company's stock valued at $244,796,000 after purchasing an additional 447,078 shares during the period.  Finally, Dimensional Fund Advisors LP grew its stake in shares of  Molina Healthcare by 20.1% during the fourth quarter. Dimensional Fund Advisors LP now owns 1,127,761 shares of the company's stock worth $195,704,000 after purchasing an additional 189,084 shares during the period. 98.50% of the stock is owned by institutional investors. </p><h2>Molina Healthcare Company Profile</h2> (Get Free Report)<p>Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.  </p><p>The company traces its roots to the early 1980s, when Dr.</p><h2>See Also</h2><ul><li>Five stocks we like better than Molina Healthcare</li><li>As Shares Fall, Analyst Are Boosting their Broadcom Price Targets</li><li>Everpure: AI Storage Uncertainty Overshadows Breakneck Growth</li><li>This Tech ETF Is Beating QQQ—and Canada May Be Part of the Reason</li><li>Intel Is the Market's Most Mispriced AI Hedge</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsEstimatesChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1PSA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="325" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsEstimatesChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1PSA"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Molina Healthcare Right Now?</h2><p>Before you consider Molina Healthcare, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.</p><p>While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>Molina Healthcare updated its FY2026 earnings guidance, setting EPS at $5.00+, below the consensus estimate of $5.18. The company recently reported Q1 earnings of $2.35 per share, beating estimates. Analysts have adjusted price targets, with Bank of America upgrading to 'Buy' and Wells Fargo raising its target. Additionally, insiders Jeff D. Barlow and Maurice Hebert sold shares, while institutional investors like AQR Capital Management increased their stakes significantly in recent quarters.</p>

Market Beat

Molina Healthcare

Centene

Wells Fargo

Mizuho Financial

Mizuho Financial Group, Inc.

Bank of America

Barclays

T. Rowe Price

Invesco

WELLS FARGO & COMPANY DP SHS REP 1/1000TH INT NCUM PFD CL A DD

WELLS FARGO & COMPANY 7.5% PERP CONV PRF CLS 'A' SERIES 'L'

WELLS FARGO & COMPANY DEP SHS REP 1/1000 INT PER PFD SER Y A

WELLS FARGO & COMPANY DP SHS REP 1/1000TH INT NCUM PFD CL A CC

WELLS FARGO & COMPANY 4.75% DEP SHS 1/1000 NCUM PFD CL A SR Z

WELLS FARGO & COMPANY DEP SHS REP 1/1000TH INT PFD SR AA (CLA)

BANK OF AMERICA CORPORATION DEP SHS REP 1/1000TH INT NON CUM PFD QQ

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200TH PRF SERIES '5'

BANK OF AMERICA CORPORATION 7.25% NON-CUM PERP CONV PFD SER L

BANK OF AMERICA CORPORATION 5.875%NON CUM DEP SHS REP1/1000TH SER HH

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200TH PRF SERIES '2'

BANK OF AMERICA CORPORATION 5% DEP SHS REPR 1/1000TH NON CUM PFD LL

BANK OF AMERICA CORPORATION DEP SHARES REP 1/1000TH PERP PFD SER 'E'

BANK OF AMERICA CORPORATION INCOME CAPITAL OBLIG NTS DUE 15/12/2066

BANK OF AMERICA CORPORATION 4.375% DP SH RP 1/1000TH IN NON CU PF NN

BANK OF AMERICA CORPORATION DEP SH REP 1/1200TH PRF SER 1 USD25

BANK OF AMERICA CORPORATION 5.375%DEP SHS REP 1/1000TH NON CUM SR KK

BANK OF AMERICA CORPORATION 6%NON CUM DEP SHS EACH REP 1/1000 SER GG

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200 PFD SER 4 USD25

BANK OF AMERICA CORPORATION DEP SHS REP 1/1000TH NON CUM PFD SER SS

BANK OF AMERICA CORPORATION 4.125%DEP SH REP 1/1000 PFD SER PP USD25

Bank of America Corp

Molina Healthcare (NYSE:MOH) Updates FY 2026 Earnings Guidance